nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Zuclopenthixol—Convulsion—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Zuclopenthixol—Hypertension—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Zuclopenthixol—Hypertension—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Zuclopenthixol—Myalgia—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Zuclopenthixol—Myalgia—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Zuclopenthixol—Eye disorder—Prednisone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Zuclopenthixol—Anxiety—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Zuclopenthixol—Drowsiness—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Zuclopenthixol—Discomfort—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Zuclopenthixol—Discomfort—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Zuclopenthixol—Dry mouth—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Zuclopenthixol—Angiopathy—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Zuclopenthixol—Malaise—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Zuclopenthixol—Malaise—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Zuclopenthixol—Vertigo—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Vertigo—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Syncope—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Syncope—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Sweating—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Zuclopenthixol—Shock—Triamcinolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Zuclopenthixol—Shock—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Betamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Tachycardia—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Tachycardia—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Zuclopenthixol—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Zuclopenthixol—Convulsion—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Zuclopenthixol—Convulsion—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Zuclopenthixol—Hypertension—Betamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Zuclopenthixol—Hypertension—Dexamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Zuclopenthixol—Myalgia—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Zuclopenthixol—Myalgia—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Zuclopenthixol—Anxiety—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Zuclopenthixol—Anxiety—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Zuclopenthixol—Discomfort—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Zuclopenthixol—Discomfort—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Zuclopenthixol—Hypotension—Methylprednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Zuclopenthixol—Pain—Prednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Zuclopenthixol—Urethral disorder—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Zuclopenthixol—Insomnia—Triamcinolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Zuclopenthixol—Insomnia—Methylprednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Zuclopenthixol—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Zuclopenthixol—Visual impairment—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Zuclopenthixol—Shock—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Zuclopenthixol—Shock—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Zuclopenthixol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Zuclopenthixol—Tachycardia—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Zuclopenthixol—Tachycardia—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Zuclopenthixol—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Zuclopenthixol—Eye disorder—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Zuclopenthixol—Tinnitus—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Zuclopenthixol—Anorexia—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Zuclopenthixol—Anorexia—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Zuclopenthixol—Fatigue—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Zuclopenthixol—Fatigue—Methylprednisolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Zuclopenthixol—Pain—Triamcinolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Zuclopenthixol—Hypotension—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Zuclopenthixol—Hypotension—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Zuclopenthixol—Angiopathy—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Zuclopenthixol—Immune system disorder—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Insomnia—Dexamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Insomnia—Betamethasone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Zuclopenthixol—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Zuclopenthixol—Paraesthesia—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Zuclopenthixol—Mental disorder—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Zuclopenthixol—Malnutrition—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Zuclopenthixol—Erythema—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Zuclopenthixol—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Zuclopenthixol—Dyspepsia—Betamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Zuclopenthixol—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Decreased appetite—Betamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zuclopenthixol—Fatigue—Betamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zuclopenthixol—Fatigue—Dexamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zuclopenthixol—Pain—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zuclopenthixol—Pain—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Zuclopenthixol—Vision blurred—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Zuclopenthixol—Malaise—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Zuclopenthixol—Vertigo—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Zuclopenthixol—Leukopenia—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Asthenia—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Abdominal pain—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Asthenia—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zuclopenthixol—Pruritus—Triamcinolone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Zuclopenthixol—Pruritus—Methylprednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zuclopenthixol—Convulsion—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Zuclopenthixol—Myalgia—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Discomfort—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Zuclopenthixol—Dizziness—Triamcinolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zuclopenthixol—Dizziness—Methylprednisolone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zuclopenthixol—Asthenia—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zuclopenthixol—Asthenia—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000995	0.000995	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000993	0.000993	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000993	0.000993	CcSEcCtD
Zuclopenthixol—Nausea—Prednisolone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Zuclopenthixol—Pruritus—Dexamethasone—psoriatic arthritis	0.000986	0.000986	CcSEcCtD
Zuclopenthixol—Pruritus—Betamethasone—psoriatic arthritis	0.000986	0.000986	CcSEcCtD
Zuclopenthixol—Skin disorder—Methotrexate—psoriatic arthritis	0.000985	0.000985	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Zuclopenthixol—Vomiting—Triamcinolone—psoriatic arthritis	0.000977	0.000977	CcSEcCtD
Zuclopenthixol—Vomiting—Methylprednisolone—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
Zuclopenthixol—Rash—Triamcinolone—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Zuclopenthixol—Dermatitis—Triamcinolone—psoriatic arthritis	0.000968	0.000968	CcSEcCtD
Zuclopenthixol—Anorexia—Methotrexate—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Zuclopenthixol—Rash—Methylprednisolone—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Zuclopenthixol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000966	0.000966	CcSEcCtD
Zuclopenthixol—Headache—Triamcinolone—psoriatic arthritis	0.000962	0.000962	CcSEcCtD
Zuclopenthixol—Headache—Methylprednisolone—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000954	0.000954	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betamethasone—psoriatic arthritis	0.000954	0.000954	CcSEcCtD
Zuclopenthixol—Hypotension—Methotrexate—psoriatic arthritis	0.000948	0.000948	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000924	0.000924	CcSEcCtD
Zuclopenthixol—Dizziness—Betamethasone—psoriatic arthritis	0.000922	0.000922	CcSEcCtD
Zuclopenthixol—Dizziness—Dexamethasone—psoriatic arthritis	0.000922	0.000922	CcSEcCtD
Zuclopenthixol—Insomnia—Methotrexate—psoriatic arthritis	0.000918	0.000918	CcSEcCtD
Zuclopenthixol—Nausea—Triamcinolone—psoriatic arthritis	0.000913	0.000913	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methotrexate—psoriatic arthritis	0.000911	0.000911	CcSEcCtD
Zuclopenthixol—Nausea—Methylprednisolone—psoriatic arthritis	0.000911	0.000911	CcSEcCtD
Zuclopenthixol—Dyspnoea—Methotrexate—psoriatic arthritis	0.000905	0.000905	CcSEcCtD
Zuclopenthixol—Somnolence—Methotrexate—psoriatic arthritis	0.000902	0.000902	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methotrexate—psoriatic arthritis	0.000893	0.000893	CcSEcCtD
Zuclopenthixol—Vomiting—Dexamethasone—psoriatic arthritis	0.000886	0.000886	CcSEcCtD
Zuclopenthixol—Vomiting—Betamethasone—psoriatic arthritis	0.000886	0.000886	CcSEcCtD
Zuclopenthixol—Decreased appetite—Methotrexate—psoriatic arthritis	0.000882	0.000882	CcSEcCtD
Zuclopenthixol—Rash—Dexamethasone—psoriatic arthritis	0.000879	0.000879	CcSEcCtD
Zuclopenthixol—Rash—Betamethasone—psoriatic arthritis	0.000879	0.000879	CcSEcCtD
Zuclopenthixol—Dermatitis—Dexamethasone—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Zuclopenthixol—Dermatitis—Betamethasone—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000876	0.000876	CcSEcCtD
Zuclopenthixol—Fatigue—Methotrexate—psoriatic arthritis	0.000875	0.000875	CcSEcCtD
Zuclopenthixol—Headache—Dexamethasone—psoriatic arthritis	0.000873	0.000873	CcSEcCtD
Zuclopenthixol—Headache—Betamethasone—psoriatic arthritis	0.000873	0.000873	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—psoriatic arthritis	0.000871	0.000871	CcSEcCtD
Zuclopenthixol—Pain—Methotrexate—psoriatic arthritis	0.000868	0.000868	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—psoriatic arthritis	0.000859	0.000859	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—psoriatic arthritis	0.000831	0.000831	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00083	0.00083	CcSEcCtD
Zuclopenthixol—Nausea—Dexamethasone—psoriatic arthritis	0.000828	0.000828	CcSEcCtD
Zuclopenthixol—Nausea—Betamethasone—psoriatic arthritis	0.000828	0.000828	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—psoriatic arthritis	0.000803	0.000803	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methotrexate—psoriatic arthritis	0.000802	0.000802	CcSEcCtD
Zuclopenthixol—Body temperature increased—Methotrexate—psoriatic arthritis	0.000802	0.000802	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—psoriatic arthritis	0.000772	0.000772	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—psoriatic arthritis	0.000765	0.000765	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—psoriatic arthritis	0.000765	0.000765	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—psoriatic arthritis	0.000761	0.000761	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000748	0.000748	CcSEcCtD
Zuclopenthixol—Asthenia—Methotrexate—psoriatic arthritis	0.000728	0.000728	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—psoriatic arthritis	0.000721	0.000721	CcSEcCtD
Zuclopenthixol—Pruritus—Methotrexate—psoriatic arthritis	0.000718	0.000718	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methotrexate—psoriatic arthritis	0.000694	0.000694	CcSEcCtD
Zuclopenthixol—Dizziness—Methotrexate—psoriatic arthritis	0.000671	0.000671	CcSEcCtD
Zuclopenthixol—Vomiting—Methotrexate—psoriatic arthritis	0.000645	0.000645	CcSEcCtD
Zuclopenthixol—Rash—Methotrexate—psoriatic arthritis	0.00064	0.00064	CcSEcCtD
Zuclopenthixol—Dermatitis—Methotrexate—psoriatic arthritis	0.000639	0.000639	CcSEcCtD
Zuclopenthixol—Headache—Methotrexate—psoriatic arthritis	0.000636	0.000636	CcSEcCtD
Zuclopenthixol—Nausea—Methotrexate—psoriatic arthritis	0.000603	0.000603	CcSEcCtD
